[go: up one dir, main page]

Rabinovitch, 1998 - Google Patents

An update on cytokines in the pathogenesis of insulin‐dependent diabetes mellitus

Rabinovitch, 1998

View PDF
Document ID
6670657040943287078
Author
Rabinovitch A
Publication year
Publication venue
Diabetes/metabolism reviews

External Links

Snippet

Correlation studies between cytokines expressed in islets and autoimmune diabetes development in NOD mice and BB rats have demonstrated that β‐cell destructive insulitis is associated with increased expression of proinflammatory cytokines (IL‐1, TNFα, and IFNα) …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Similar Documents

Publication Publication Date Title
Rabinovitch An update on cytokines in the pathogenesis of insulin‐dependent diabetes mellitus
Rabinovitch et al. Role of cytokines in the pathogenesis of autoimmune diabetes mellitus
Lafaille The role of helper T cell subsets in autoimmune diseases
Faria et al. Oral tolerance
Hanninen et al. γδ T cells as mediators of mucosal tolerance: the autoimmune diabetes model.
Ploix et al. Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.
USRE43467E1 (en) Treatment of autoimmune disease
Rabinovitch Immunoregulation by cytokines in autoimmune diabetes
Ablamunits et al. Islet T cells secreting IFN-γ in NOD mouse diabetes: arrest by p277 peptide treatment
US7041634B2 (en) Method of inhibiting immune system destruction of transplanted viable cells
Ludvigsson Therapies to preserve β-cell function in type 1 diabetes
Kim et al. NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL‐10 and transforming growth factor β, and by clonally deleting antigen‐specific T cells
Pearson et al. Redirecting Th1 and Th2 responses in autoimmune disease
Bach Non‐Th2 regulatory T‐cell control of Th1 autoimmunity
Adorini et al. Targeting IL-12, the key cytokine driving Th1-mediated autoimmune diseases
Coffman et al. Redirection of Th1 and Th2 responses
Meagher et al. Cytokines and chemokines in the pathogenesis of murine type 1 diabetes
Kang et al. Regulatory T cells in lupus
EP0883406B1 (en) Use of il-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular
Bergman et al. Autoreactive T-cell clones from the nonobese diabetic mouse
Bardos et al. Continuous nasal administration of antigen is critical to maintain tolerance in adoptively transferred autoimmune arthritis in SCID mice
AU721737B2 (en) Method of inhibiting immune system destruction of transplanted viable cells
WO1997011607A9 (en) Method of inhibiting immune system destruction of transplanted viable cells
Chen et al. Role of regulatory T cells in the pathogenesis of autoimmune diabetes
EP0877555B1 (en) Use of an inhibitor of an immune system costimulation event for the preparation of a medicament inhibiting the immune system destruction of transplanted viable non-embryonic cells